Hinderer; Christian

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hinderer; Christian.The latest application filed is for "adeno-associated viral vectors useful in treatment of spinal muscular atropy".

Company Profile

11.6.21

Hinderer; Christian - New Orleans LA
Hinderer; Christian - Baltimore MD
Hinderer; Christian - Philadelphia PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Adeno-associated Viral Vectors Useful In Treatment Of Spinal Muscular Atropy App 20220265861 - Wilson; James M. ; et al.	2022-08-25
Recombinant Adeno-associated Virus For Treatment Of Grn-associated Adult-onset Neurodegeneration App 20220136008 - Wilson; James M. ; et al.	2022-05-05
Gene Therapy For Treating Mucopolysaccharidosis Type Ii App 20220125949 - Hinderer; Christian ; et al.	2022-04-28
Aav-epo For Treating Companion Animals App 20220056090 - Hinderer; Christian ; et al.	2022-02-24
Gene therapy for treating mucopolysaccharidosis type II Grant 11,253,612 - Hinderer , et al. February 22, 2	2022-02-22
Intrathecal Administration Of Adeno-associated-viral Vectors For Gene Therapy App 20210379202 - Wilson; James M. ; et al.	2021-12-09
Intrathecal administration of adeno-associated-viral vectors for gene therapy Grant 11,135,313 - Wilson , et al. October 5, 2	2021-10-05
AAV-EPO for treating companion animals Grant 11,117,942 - Hinderer , et al. September 14, 2	2021-09-14
Gene Therapy For Treating Mucopolysaccharidosis Type I App 20210228740 - Hinderer; Christian ; et al.	2021-07-29
Gene therapy for treating mucopolysaccharidosis type I Grant 10,973,929 - Hinderer , et al. April 13, 2	2021-04-13
Methods And Compositions For Treating Metastatic Breast Cancer And Other Cancers In The Brain App 20200368368 - Wilson; James M. ; et al.	2020-11-26
Methods and compositions for treating metastatic breast cancer and other cancers in the brain Grant 10,780,182 - Wilson , et al. Sept	2020-09-22
Gene Therapy For Mucopolysaccharidosis Iiib App 20200289675 - Wilson; James M. ; et al.	2020-09-17
Gene Therapy For Treating Mucopolysaccharidosis Type Ii App 20200246439 - Kind Code	2020-08-06
Gene Therapy For Ceroid Lipofuscinoses App 20200239908 - Wilson; James M. ; et al.	2020-07-30
Aav9-mediated Gene Therapy For Treating Mucopolysaccharidosis Type I App 20200147185 - Hinderer; Christian ; et al.	2020-05-14
Compositions Useful in Treatment of Spinal Muscular Atrophy App 20200056205 - Wilson; James M. ; et al.	2020-02-20
Aav-anti-vegf For Treating Cancer In Companion Animals App 20190292250 - Hinderer; Christian ; et al.	2019-09-26
Gene Therapy For Treating Mucopolysaccharidosis Type Ii App 20190070311 - Hinderer; Christian ; et al.	2019-03-07
Gene Therapy For Treating Mucopolysaccharidosis Type I App 20190038772 - Hinderer; Christian ; et al.	2019-02-07
Adeno-associated Viral Vectors Useful In Treatment Of Spinal Muscular Atropy App 20180353624 - Wilson; James M. ; et al.	2018-12-13
Intrathecal Administration Of Adeno-associated-viral Vectors For Gene Therapy App 20180339065 - Wilson; James M. ; et al.	2018-11-29
Aav-epo For Treating Companion Animals App 20180251508 - Hinderer; Christian ; et al.	2018-09-06
Glp-1 And Use Thereof In Compositions For Treating Metabolic Diseases App 20180230488 - Hinderer; Christian ; et al.	2018-08-16
Veterinary composition and methods for non-surgical neutering and castration Grant 9,770,011 - Wilson , et al. September 26, 2	2017-09-26
Methods And Compositions For Treating Metastatic Breast Cancer And Other Cancers In The Brain App 20170043035 - Wilson; James M. ; et al.	2017-02-16
Veterinary Composition And Methods For Non-surgical Neutering And Castration App 20150230430 - Wilson; James M. ; et al.	2015-08-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.